| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Altered fatty acid metabolism rewires cholangiocarcinoma stemness features
|
Lori, G.
|
|
|
55 |
S3 |
p. S225-S226
|
artikel
|
| 2 |
A machine learning enabled score based on large varices predicts 5- and 10-year hepatocellular carcinoma (HCC) development in a 12-year prospective cohort of patients with compensated advanced chronic liver disease
|
Ascari, S.
|
|
|
55 |
S3 |
p. S221
|
artikel
|
| 3 |
An innovative patient-specific cholangiocarcinoma-on-chip as a platform for personalized therapy
|
Polidoro, M.A.
|
|
|
55 |
S3 |
p. S223-S224
|
artikel
|
| 4 |
Clinical impact of relative dose intensity of cabozantinib during the first 8 weeks and of subsequent dose reductions in patients with unresectable hepatocellular carcinoma
|
Tovoli, F.
|
|
|
55 |
S3 |
p. S224-S225
|
artikel
|
| 5 |
Comprehensive characterization of viral integrations in HBV-infected intrahepatic cholangiocarcinomas
|
Musolino, C.
|
|
|
55 |
S3 |
p. S213
|
artikel
|
| 6 |
Dynamic evolution of circulating tumor DNA in patients with hepatocellular carcinoma across tumor stages and treatments
|
Campani, C.
|
|
|
55 |
S3 |
p. S213-S214
|
artikel
|
| 7 |
Early post-treatment changes in body composition parameters are associated with overall survival and need of transplantation in cirrhotic patients with HCC undergoing locoregional treatments
|
Parisse, S.
|
|
|
55 |
S3 |
p. S220
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
55 |
S3 |
p. i-ii
|
artikel
|
| 9 |
Efficacy of nivolumab monotherapy in cirrhotic patients with advanced hepatocellular carcinoma: a single-center retrospective study
|
Frigo, F.
|
|
|
55 |
S3 |
p. S212-S213
|
artikel
|
| 10 |
Hepatitis D virus-associated hepatocellular carcinoma, characteristics and outcome: An Italian Liver Cancer (ITA.LI.CA) study
|
Pasta, A.
|
|
|
55 |
S3 |
p. S215
|
artikel
|
| 11 |
Hepatocellular Carcinoma in HIV-Infected Patients: Clinical Presentation and Outcomes
|
Alimenti, E.
|
|
|
55 |
S3 |
p. S224
|
artikel
|
| 12 |
How field practice complies with BCLC 2022 recommendations for hepatocellular carcinoma management
|
Alimenti, E.
|
|
|
55 |
S3 |
p. S226
|
artikel
|
| 13 |
Impact of digital hepatological network on the referrals of HCC patients: Preliminary results
|
Zeni, N.
|
|
|
55 |
S3 |
p. S217-S218
|
artikel
|
| 14 |
Impact of ISO score on oncological outcomes and survival in liver transplant candidates with hepatocellular carcinoma
|
Pinto, E.
|
|
|
55 |
S3 |
p. S215
|
artikel
|
| 15 |
Impact of laparoscopic liver resection for access to the waiting list of a single regional liver transplant center in southern Italy: entry and dropout flows’ analysis
|
Pagano, D.
|
|
|
55 |
S3 |
p. S216
|
artikel
|
| 16 |
Inhibition of the Extracellular Signal-Regulated Kinase ERK5 induces an increased expression of the Epidermal Growth Factor receptor and sensitizes hepatocarcinoma cells to gefitinib
|
Menconi, A.
|
|
|
55 |
S3 |
p. S214
|
artikel
|
| 17 |
Liposomal doxorubicin targeted with the Fab' of atezolizumab as a novel strategy against HCC
|
Gabbia, D.
|
|
|
55 |
S3 |
p. S223
|
artikel
|
| 18 |
Liver transplantation for metastatic colorectal cancer after optimal systemic treatment (COLT trial): feasibility and safety data
|
Mazzaferro, V.
|
|
|
55 |
S3 |
p. S214-S215
|
artikel
|
| 19 |
Liver transplantation for perihilar cholangiocarcinoma after neoadjuvant chemoradiation with brachytherapy versus stereotactic beam radiotherapy: Pretransplant toxicity and posttransplant outcomes
|
Maspero, M.
|
|
|
55 |
S3 |
p. S220
|
artikel
|
| 20 |
Long term outcome of patients with hepatocellular carcinoma treated with transarterial radioembolization
|
Prussia, C.
|
|
|
55 |
S3 |
p. S219
|
artikel
|
| 21 |
MerTK-expressing macrophages promote the malignant features of cholangiocarcinoma cells
|
Pastore, M.
|
|
|
55 |
S3 |
p. S226
|
artikel
|
| 22 |
Metabolic dysfunction and DNA damage of exhausted tumor-infiltrating CD8 T-cells in hepatocellular carcinoma
|
Montali, A.
|
|
|
55 |
S3 |
p. S213
|
artikel
|
| 23 |
Outcomes of Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced hepatocellular carcinoma in the era of immunotherapy: A real-life comparison with best supportive care
|
Stefanini, B.
|
|
|
55 |
S3 |
p. S222-S223
|
artikel
|
| 24 |
Predicting Early Recurrence in Hepatocellular Carcinoma: Leveraging Machine Learning for Enhanced Prognosis and Personalized Treatment
|
Giuffrè, M.
|
|
|
55 |
S3 |
p. S211
|
artikel
|
| 25 |
Predictors of extrahepatic progression in patients with hepatocellular carcinoma receiving transarterial chemoembolization
|
Pinto, E.
|
|
|
55 |
S3 |
p. S218
|
artikel
|
| 26 |
Prophylaxis of HBV-recurrence after liver transplantation in patients with HCC: Risk of HCC recurrence from a large, multicentre retrospective study from Italy
|
Battistella, S.
|
|
|
55 |
S3 |
p. S227
|
artikel
|
| 27 |
Sequential systemic treatments for hepatocellular carcinoma: real-life clinical practice data in the time of multiple agents
|
Tovoli, F.
|
|
|
55 |
S3 |
p. S211-S212
|
artikel
|
| 28 |
Systematic review and meta-analysis of safety and efficacy of atezolizumab/ bevacizumab in Child-Pugh class B patients with hepatocellular carcinoma
|
Pasta, A.
|
|
|
55 |
S3 |
p. S221
|
artikel
|
| 29 |
Targeting the AAA+ ATPase RuvBL1 reduces mTOR-driven NASH-HCC development in mice
|
Guida, A.
|
|
|
55 |
S3 |
p. S225
|
artikel
|
| 30 |
The expression of Aurora Kinase A and its potential role as a regulator of Programmed Death-Ligand 1 in hepatocellular carcinoma: Implications for immunotherapy and immune checkpoint regulation in hepatocarcinogenesis
|
Grisetti, L.
|
|
|
55 |
S3 |
p. S219-S220
|
artikel
|
| 31 |
The impact of the onset of Hepatocellular Carcinoma on the natural history of cirrhosis
|
Martini, A.
|
|
|
55 |
S3 |
p. S212
|
artikel
|
| 32 |
Towards a rational approach to priority in liver transplant oncology
|
Sposito, C.
|
|
|
55 |
S3 |
p. S219
|
artikel
|
| 33 |
Tracing anti-cancer immunity in patients undergoing liver transplantation for HCC after downstaging with immunotherapy
|
Bhoori, S.
|
|
|
55 |
S3 |
p. S217
|
artikel
|
Tijdschrift beschrijving